Ionic basis of pharmacological therapy in Brugada syndrome


Por: Márquez M.F., Salica G., Hermosillo A.G., Pastelín G., Gómez-Flores J., Nava S., Cárdenas M.

Publicada: 1 ene 2007
Resumen:
Pharmacotherapy of Brugada syndrome. An implantable cardioverter- defibrillator is considered the only effective therapy to terminate ventricular arrhythmias in symptomatic patients with Brugada syndrome. However, it does not prevent future arrhythmic episodes. Only antiarrhythmic drug therapy can prevent them. There have been several reports of a beneficial effect of oral quinidine in both asymptomatic and symptomatic patients. Other possible beneficial oral agents could be Ito blockers. Intravenous isoproterenol has been reported to be especially useful in abolishing arrhythmic storms in emergency situations. Also, isolated case reports on the usefulness of cilostazol, sotalol, and mexiletine have been described. The present article reviews the mechanisms by which these drugs may act and their possible role in the pharmacotherapy of this disease. © 2007 by Futura Publishing Company, Inc.

Filiaciones:
Márquez M.F.:
 Department of Electrocardiology, Instituto Nacional de Cardiología Ignacio Chávez, México, D.F., Mexico

 Instituto Nacional de Cardiología Ignacio Chávez, Departamento de Electrocardiología, Juan Badiano 1, Tlalpan 14080, México, D.F., Mexico

Salica G.:
 Department of Electrocardiology, Instituto Nacional de Cardiología Ignacio Chávez, México, D.F., Mexico

Hermosillo A.G.:
 Department of Electrocardiology, Instituto Nacional de Cardiología Ignacio Chávez, México, D.F., Mexico

Pastelín G.:
 Department of Pharmacology, Instituto Nacional de Cardiología Ignacio Chávez, México, D.F., Mexico

Gómez-Flores J.:
 Department of Electrocardiology, Instituto Nacional de Cardiología Ignacio Chávez, México, D.F., Mexico

Nava S.:
 Department of Electrocardiology, Instituto Nacional de Cardiología Ignacio Chávez, México, D.F., Mexico

Cárdenas M.:
 Department of Electrocardiology, Instituto Nacional de Cardiología Ignacio Chávez, México, D.F., Mexico
ISSN: 10453873
Editorial
BLACKWELL PUBLISHING, 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND, Estados Unidos America
Tipo de documento: Article
Volumen: 18 Número: 2
Páginas: 234-240
WOS Id: 000243562800023
ID de PubMed: 17338775